RUA — Rua Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- £6.67m
- £6.62m
- £2.18m
Annual cashflow statement for Rua Life Sciences, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.609 | -0.816 | -1.45 | -2.07 | -2 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.042 | 0.003 | -0.006 | -0.14 | -0.201 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.073 | 0.181 | -0.229 | -0.458 | 0.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.422 | -0.438 | -1.41 | -2.35 | -1.15 |
| Capital Expenditures | -0.001 | -0.005 | -0.62 | -0.904 | -0.449 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.139 | 0.007 | -0.332 | -0.008 | -0.028 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.14 | 0.002 | -0.952 | -0.912 | -0.477 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.55 | 0 | 6.68 | -0.066 | 0.132 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.99 | -0.436 | 4.32 | -3.33 | -1.48 |